Clinical practice guidelines for IgG4‐related sclerosing cholangitis

Abstract

IgG4‐related sclerosing cholangitis (IgG4‐ SC ) is a distinct type of cholangitis frequently associated with autoimmune pancreatitis and currently recognized as a biliary manifestation of IgG4‐related disease. Although clinical diagnostic criteria of IgG4‐ SC were established in 2012, differential diagnosis from primary sclerosing cholangitis and cholangiocarcinoma is sometimes difficult. Furthermore, no practical guidelines for IgG4‐ SC are available. Because the evidence level of most articles retrieved through searching the PubMed, Cochrane Library, and Igaku Chuo Zasshi databases was below C based on the systematic review evaluation system of clinical practice guidelines MINDS 2014, we developed consensus guidelines using the modified Delphi approach. Three committees (a guideline creating committee, an expert panelist committee for rating statements according to the modified Delphi method, and an evaluating committee) were organized. Eighteen clinical questions ( CQ s) with clinical statements were developed regarding diagnosis (14 CQ s) and treatment (4 CQ s). Recommendation levels for clinical statements were set using the modified Delphi approach. The guidelines explain methods for accurate diagnosis, and safe and appropriate treatment of IgG4‐ SC .

References 162

1. 1.

   Nakazawa T, Naitoh I, Hayashi K, Okumura F, Miyabe K, Yoshida M, et al. Diagnostic criteria for IgG4‐related sclerosing cholangitis based on cholangiographic classification. J Gastroenterol 2012;47:79–87.

   Not in our library10.1007/s00535-011-0465-z

2. 2.

   Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4‐related disease. Lancet. 2015;385:1460–71.

   Not in our library10.1016/s0140-6736(14)60720-0

3. 3.

   Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of IgG4‐related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci. 2012;19:536–42.

   Not in our library10.1007/s00534-012-0521-y

4. 4.

   Minds Guideline Center, Japan Council for Quality Health Care. Minds handbook for clinical practice guideline development 2014. 2014 Available from URL: https://minds.jcqhc.or.jp/s/guidance

   Not in our library

5. 5.

   Fitch K, Bernstein SJ, Aguilar MS. The RAND/UCLA appropriateness method user's manual. Santa Monica: RAND; 2001.

   Not in our library

6. 6.

   Okazaki K, Kawa S, Kamisawa T, Ito T, Inui K, Irie H, et al. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2013 I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol 2014;49:567–88.

   Not in our library10.1007/s00535-014-0942-2

7. 7.

   The AGREE Next Steps Consortium. Appraisal of guidelines for research & evaluation II (AGREE II), 2017 Available from URL: http://www.agreetrust.org

   Not in our library

8. 8.

   Kamisawa T, Funata N, Hayashi Y, Tsuruta K, Okamoto A, Amemiya K, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003;52:683–7.

   Not in our library10.1136/gut.52.5.683

9. 9.

   Okazaki K, Uchida K, Fukui T. Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol. 2008;43:409–18.

   Not in our library10.1007/s00535-008-2190-9

10. 10.

    Waldram R, Kopelman H, Tsantoulas D, Wiliams R. Chronic pancreatitis, sclerosing pancreatitis, sclerosing cholangitis, and sicca complex in two siblings. Lancet. 1975;1:550–2.

    Not in our library10.1016/s0140-6736(75)91560-3

11. 11.

    Sjögren I, Wengle B, Korsgren M. Primary sclerosing cholangitis associated with fibrosis of submandibular glands and the pancreas. Acta Med Scand. 1979;205:139–41.

    Not in our library10.1111/j.0954-6820.1979.tb06019.x

12. 12.

    Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991;22:387–95.

    Not in our library10.1016/0046-8177(91)90087-6

13. 13.

    Nakazawa T, Ohara H, Yamada T, Ando H, Sano H, Kajino S, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology. 2001;48:621–6.

    Not in our library

14. 14.

    Nakazawa T, Ohara H, Sano H, Ando H, Aoki S, Kobayashi S, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas. 2005;30:20–5.

    Not in our library

15. 15.

    Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, et al. IgG4‐related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis‐associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193–203.

    Not in our library10.1097/01.pas.0000136449.37936.6c

16. 16.

    Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4‐associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706–15.

    Not in our library10.1053/j.gastro.2007.12.009

17. 17.

    Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, et al. Recommendations for the nomenclature of IgG4‐related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061–7.

    Not in our library10.1002/art.34593

18. 18.

    Nakazawa T, Ohara H, Sano H, Ando T, Joh T. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32:229.

    Not in our library10.1097/01.mpa.0000202941.85955.07

19. 19.

    Tanaka A, Tazuma S, Okazaki K, Nakazawa T, Inui K, Chiba T, et al. Clinical features, response to treatment, and outcomes of IgG4‐related sclerosing cholangitis. Clin Gastroenterol Hapatol. 2017;15:920–6.

    Not in our library10.1016/j.cgh.2016.12.038

20. 20.

    Naitoh I, Nakazawa T, Ohara H, Ando T, Hayashi K, Tanaka H, et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4‐related sclerosing cholangitis. J Gastroenterol. 2009;44:1147–55.

    Not in our library10.1007/s00535-009-0108-9

21. 21.

    Graham R, Smyrk T, Chari S, Takahashi N, Zhang L. Isolated IgG4‐related sclerosing cholangitis: a report of 9 cases. Hum Pathol. 2014;45:1722–9.

    Not in our library10.1016/j.humpath.2014.04.006

22. 22.

    Ohara H, Nakazawa T, Kawa S, Kamisawa T, Uchida K, Hirano K, et al. Establishment of a serum IgG4 cut‐off value for the differential diagnosis of IgG4‐related sclerosing cholangitis: a Japanese cohort. J Gastroenterol Hepatol. 2013;28:1247–51.

    Not in our library10.1111/jgh.12248

23. 23.

    Tanaka A, Tazuma S, Okazaki K, Tsubouchi H, Inui K, Takikawa H, et al. Nationwide survey for primary sclerosing cholangitis and IgG4‐related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci. 2014;21:43–50.

    Not in our library10.1002/jhbp.50

24. 24.

    Nakazawa T, Ikeda Y, Kawaguchi Y, Kitagawa H, Takada H, Takeda Y, et al. Isolated intrapancreatic IgG4‐related sclerosing cholangitis. World J Gastroenterol. 2015;21:1334–43.

    Not in our library10.3748/wjg.v21.i4.1334

25. 25.

    Hirano K, Tada M, Isayama H, Yamamoto K, Mizuno S, Yagioka H, et al. Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitis. Gastrointest Endosc. 2010;71:85–90.

    Not in our library10.1016/j.gie.2009.08.008

26. 26.

    Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino‐Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352–8.

    Not in our library10.1097/mpa.0b013e3182142fd2

27. 27.

    Lindor KD, LaRusso NF. Primary sclerosing cholangitis In: Schiff ER, Sorrell MF, Maddreg AC, editors. Disease of the liver 9th. Philadelphia: Lippincott WW; 2003 p. 603–84.

    Not in our library

28. 28.

    Tabibian JH, O'Hara SP, Lindor KD. Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies. Scand J Gastroenterol 2014;49:901–8.

    Not in our library10.3109/00365521.2014.913189

29. 29.

    Nakazawa T, Notohara K, Tazuma S, Tanaka A, Isayama H, Tsuyuguchi T, et al. The 2016 diagnostic criteria for primary sclerosing cholangitis. J Gastroenterol. 2017;52:838–44.

    Not in our library10.1007/s00535-016-1286-x

30. 30.

    Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y. Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients. Hepatol Res. 2004;29:153–9.

    Not in our library10.1016/j.hepres.2004.03.006

31. 31.

    Lindor KD, Kowdley KV, Harrison ME. ACG clinical guideline. Primary sclerosing cholangitis. Am J Gastroenterol. 2015;110:646–59.

    Not in our library10.1038/ajg.2015.112

32. 32.

    Chapman R, Fevery J, Kalloo A, Nagomey DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–78.

    Not in our library10.1002/hep.23294

33. 33.

    Ludwig J, Czaja AJ, Dickson ER, LaRusso NF, Wiesner RH. Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology. Liver. 1984;4:105–16.

    Not in our library10.1111/j.1600-0676.1984.tb00914.x

34. 34.

    Poropat G, Giljaca V, Stimac D, Gluud C. Bile acids for primary sclerosing cholangitis. Cochrane Database Syst Rev 2011;CD003626.

    Not in our library10.1002/14651858.cd003626.pub2

35. 35.

    Triantos CK, Koukias NM, Nikolopoulou VN, Burroughs AK. Meta‐analysis: ursodeoxycholic acid for primary sclerosing cholangitis. Aliment Pharmacol Ther. 2011;34:901–10.

    Not in our library10.1111/j.1365-2036.2011.04822.x

36. 36.

    Othman MO, Dunkelberg J, Roy PK. Urosdeoxycholic acid in primary sclerosing cholangitis: a meta‐analysis and systematic review. Arab J Gastroenterol. 2012;13:103–10.

    Not in our library10.1016/j.ajg.2012.06.011

37. 37.

    O'Mahony CA, Vierling JM. Etiopathogenesis of primary sclerosing cholangitis. Semin Liver Dis. 2006;26:3–21.

    Not in our library10.1055/s-2006-933559

38. 38.

    Tazuma S. Primary sclerosing cholangitis (in Japanese) In: Yazaki Y, editors. Asakura Internal Medicine 10th. Tokyo: Asakura Shoten; 2003 p. 1144–6.

    Not in our library

39. 39.

    Zen Y. The pathology of IgG4‐related disease in the bile duct and pancreas. Semin Liver Dis. 2016;36:242–56.

    Not in our library10.1055/s-0036-1584319

40. 40.

    Nishino T, Toki F, Oyama H, Oi I, Kobayashi M, Takasaki K, et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas. 2005;30:76–82.

    Not in our library

Cited by papers we hold 1

• IgG4-Related Disease With Gastrointestinal Involvement: Case Reports and Literature Review · 2022
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.